DeCIDE: A phase III randomized trial of docetaxel, cisplatin, 5-fluorouracil, (TPF) induction chemotherapy in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck

Reporter: J Taylor Whaley
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de junio del 2012

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

AACR: Markers Hint at Who Cancer Treatments Could Help

Nov 29, 2015

Meeting at cancer conference discusses possible role of TIMP-1, Trim62, CYP2D6 phenotype

ASCO Endorses ASTRO Guidelines for Endometrial Cancer

Jul 9, 2015

Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases

ASCO Endorses Guideline for Radiation After Prostatectomy

Nov 6, 2014

Guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer